Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest drug half life time in humans after IV administration.
Constraint: You must select all options from a, b, c, d, or e without using any additional words.
Options:
[a] CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21
[b] CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O
[c] CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
[d] CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C
[e] C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O
Answer: c
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone